- Home
- PMD vs IMRN Comparison
PMD vs IMRN Comparison
Compare PMD & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMD
- IMRN
- Stock Information
- Founded
- PMD 1986
- IMRN 1994
- Country
- PMD United States
- IMRN Australia
- Employees
- PMD N/A
- IMRN N/A
- Industry
- PMD Medical Specialities
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- PMD Health Care
- IMRN Health Care
- Exchange
- PMD Nasdaq
- IMRN Nasdaq
- Market Cap
- PMD 13.3M
- IMRN 13.3M
- IPO Year
- PMD N/A
- IMRN N/A
- Fundamental
- Price
- PMD $2.32
- IMRN $2.68
- Analyst Decision
- PMD
- IMRN
- Analyst Count
- PMD 0
- IMRN 0
- Target Price
- PMD N/A
- IMRN N/A
- AVG Volume (30 Days)
- PMD 37.5K
- IMRN 4.2K
- Earning Date
- PMD 11-07-2024
- IMRN 09-27-2024
- Dividend Yield
- PMD N/A
- IMRN N/A
- EPS Growth
- PMD N/A
- IMRN N/A
- EPS
- PMD N/A
- IMRN N/A
- Revenue
- PMD $20,787,000.00
- IMRN $3,271,194.00
- Revenue This Year
- PMD N/A
- IMRN N/A
- Revenue Next Year
- PMD N/A
- IMRN N/A
- P/E Ratio
- PMD N/A
- IMRN N/A
- Revenue Growth
- PMD N/A
- IMRN 171.67
- 52 Week Low
- PMD $1.63
- IMRN $1.48
- 52 Week High
- PMD $4.04
- IMRN $5.96
- Technical
- Relative Strength Index (RSI)
- PMD 57.36
- IMRN 55.14
- Support Level
- PMD $2.27
- IMRN $2.52
- Resistance Level
- PMD $2.31
- IMRN $2.80
- Average True Range (ATR)
- PMD 0.02
- IMRN 0.18
- MACD
- PMD 0.00
- IMRN -0.00
- Stochastic Oscillator
- PMD 91.67
- IMRN 55.56
About PMD Psychemedics Corporation
Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. They provide testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples. Geographically it generates the majority of its revenue from the United States.
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.